Oncologix Tech, Inc.
OCLG
$0.0001
$0.000.00%
OTC PK
| 05/31/2016 | 05/31/2015 | ||||
|---|---|---|---|---|---|
| Net Income | -- | -16.43% | |||
| Total Depreciation and Amortization | -- | -8.26% | |||
| Total Amortization of Deferred Charges | -- | 169.20% | |||
| Total Other Non-Cash Items | -- | -39.40% | |||
| Change in Net Operating Assets | -- | 351.56% | |||
| Cash from Operations | -- | -17.73% | |||
| Capital Expenditure | -- | -133.33% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -302.73% | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -- | -301.86% | |||
| Total Debt Issued | -- | 93.62% | |||
| Total Debt Repaid | -- | -141.68% | |||
| Issuance of Common Stock | -- | -100.00% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | -- | 31.62% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -- | -135.34% | |||